Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01114997 · ClinicalTrials.gov registry record · Phase 4
Effect of Lidocaine and Esmolol to Improve the Quality of Recovery
A Phase 4 study, sponsored by Cedars-Sinai Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 32
- Enrollment target
NCT01114997 is a Phase 4 study that was terminated before completion, run by Cedars-Sinai Medical Center. The registered enrollment target is 32 participants.
The verdict
NCT01114997, a Phase 4 study, was terminated before completion, sponsored by Cedars-Sinai Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this prospective, randomized, double-blinded, active-controlled study is: To assess the effectiveness of systemic administration of lidocaine and esmolol in combination (vs. either drug alone) will result in improved postoperative outcomes for patients undergoing abdominal surgery (e.g., less pain and postoperative constipation, nausea and vomiting, faster return of bowel function, resumption of normal activities of daily living), leading to a shorten length of hospital stay, maintaining hemodynamic stability during general anesthesia, when administered as intravenous adjuvants
Interventions
- DRUG Lidocaine
- DRUG Esmolol
- DRUG Lidocaine + Esmolol (Combo)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2010-04 |
| Est. Completion | 2015-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01114997
The ClinicalTrials.gov registry entry for NCT01114997 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Lidocaine is the first listed.
NCT01114997 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01114997 about?
NCT01114997 is a clinical study titled "Effect of Lidocaine and Esmolol to Improve the Quality of Recovery". The purpose of this prospective, randomized, double-blinded, active-controlled study is: To assess the effectiveness of systemic administration of lidocaine and esmolol in combination (vs. either drug alone) will result in improved postoperative outcomes for patients undergoing abdominal surgery (e...
What is the current status of trial NCT01114997?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2010-04. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01114997?
The interventions under investigation include: Lidocaine (DRUG), Esmolol (DRUG), Lidocaine + Esmolol (Combo) (DRUG).
Who is sponsoring clinical trial NCT01114997?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.